Phase 1/2Active, not recruitingAge-related condition
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage (RAINBOW-Hx)
Phase I/II Trial of Intracerebral Transplantation of Autologous Bone Marrow Stromal Cells Combined With Recombinant Peptide Scaffold for Patients With Chronic Intracerebral Hemorrhage
- Sponsor
- Hokkaido University Hospital (Academic or other)
- Enrolment
- 8 planned
- Conditions
- Intracerebral Hemorrhage
- Interventions
- HUFF-01
- Ages
- adults, older adults
- Registry
- NCT06361433
Full record on ClinicalTrials.gov
From the registry
The goal of this clinical trial is to test intracerebral transplantation of stem cell product in patient with chronic intracerebral hemorrhage. The main questions aims to answer are: * The safety of the product * The efficacy of the product
Primary outcomes
- Number of participants with treatment-related adverse events as assessed by CTCAE v5.0
History
Primary completion expected
Last registry update
Registered
Started